Sellas Life Sciences nce $ 20 lab los ntawm pej xeem muab cov khoom lag luam, lav

Sellas Life Sciences Group Inc.
SLS,
-53.25%

tau hais rau hnub Friday tias nws tau nce $ 20.0 lab, los ntawm kev muag pej xeem ntawm kev sib koom ua ke thiab kev lees paub los yuav cov khoom lag luam. Shares ntawm lub tuam txhab biopharmaceutical, uas yog tsom rau kev kho mob qog noj ntshav, poob 43.1% hauv kev ua lag luam ua ntej, tom qab qhov muab tau pib tshaj tawm yam tsis muaj nqe lus lig Thursday. Qhov ntawd tso cov khoom lag luam rau hauv cov ntaub ntawv poob ib hnub, tshaj li cov ntaub ntawv yav dhau los muag ntawm 33.0% thaum Lub Kaum Hli 19, 1987, ib hnub uas paub ntawm Wall Street li Dub Monday. Lub tuam txhab tau hais tias nws muag 7.22 lab cov khoom sib koom, nrog rau cov ntawv tso cai los yuav txog 7.22 feem pua, ntawm $ 2.77 ib feem thiab nrog daim ntawv tso cai. Daim ntawv tso cai yuav siv tau tam sim ntawd, thiab yuav tas rau tsib xyoos. Cov khoom lag luam tau nce 50.0% nyob rau peb lub hlis dhau los txog rau hnub Thursday, thaum iShares Biotechnology pauv- pauv nyiaj
IB,
-1.40%

tau poob 3.4% thiab S&P 500
SPX,
-1.18%

tau poob 0.4%.

Tau qhov twg los: https://www.marketwatch.com/story/sellas-life-sciences-raises-20-million-from-public-offering-of-stock-warrants-10bd1276?siteid=yhoof2&yptr=yahoo